Clinical Trials Directory

Trials / Completed

CompletedNCT02520531

Scorpio Posterior Stabilised (PS) vs Scorpio NRG ("Energize") PS - Total Knee Arthroplasty

Scorpio PS vs Scorpio NRG PS - Total Knee Arthroplasty Comparative Investigation of Function

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
84 (actual)
Sponsor
Stryker Orthopaedics · Industry
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Single-centre, prospective, randomized comparative study to compare the maximum flexion and Chair Raise achievement ratios of the Scorpio PS and and the Scorpio NRG PS. Documentation of all complications.

Detailed description

Surveillance design: Single-centre, prospective, randomized comparative study. Objectives: To compare the maximum flexion (active and passive) and Chair Raise achievement ratios. All complications will be documented. Number of subjects to be enrolled: All consecutive Scorpio patients are included until a group size of 88 is reached. Clinical evaluations: Chair raise test, Stair climb test, Western Ontario McMaster Osteoarthritis Index (WOMAC) patient self evaluation, EuroQuol - 5 dimension (EQ-5D) patient questionnaire. Standard clinical, functional and pain parameters (Knee Society Score), pre-operatively and post-operatively. All per- and post-op complications.

Conditions

Interventions

TypeNameDescription
DEVICEScorpio PS (posterior stable)Implantation of total knee prosthesis
DEVICEScorpio NRG PSImplantation of total knee prosthesis

Timeline

Start date
2010-09-01
Primary completion
2018-06-28
Completion
2018-06-28
First posted
2015-08-13
Last updated
2024-02-22
Results posted
2019-09-20

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02520531. Inclusion in this directory is not an endorsement.